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Neonatal hypoxic ischemic brain injury is a signiﬁcant
cause of mortality and lifelong neurological morbidity.
Despite its public health signiﬁcance, little is know about
the underlying molecular pathways linking hypoxia to
neuronal ischemia and cell death. In this issue of Neuro-
toxicity Research, Li et al. show that the integrin b8i s
upregulated in cultured astrocytes in response to hypoxia,
which subsequently activates a TGFb-dependant neuro-
protective pathway. These ﬁndings support a novel func-
tion for astrocyte-derived integrin b8 and sheds light on the
molecular mechanisms underlying hypoxic ischemic brain
injury.
TGFb-mediated Cytoprotection
TGFb is a pleotropic cytokine with well-characterized
cytoprotective and apoptotic effects (Annes et al. 2003;
Flanders et al. 1998; Unsicker and Krieglstein 2002).
Whether TGFb promotes cell survival or induces apop-
tosis depends largely on the cellular and environmental
context, as well as the speciﬁcity of TGFb activation and
signaling. This speciﬁcity is achieved through various
mechanisms including pericellular extracellular matrix
localization, regulated liberation of active TGFb from its
latent form, and a vast array of intracellular signaling
molecules integrating TGFb effects on target tissues. The
integrin avb8 is a critical activator of TGFb in vitro and
in vivo. Using cell culture assays, Cambier et al. (2005)
showed that astrocyte-derived avb8 binds to and activates
TGFb, which then transactivates vascular endothelial cell
TGFb dependent signaling. Conditional deletion of b8
from dendritic cells abrogates TGFb-mediated activation
of regulatory T cells and results in an immunophenotype
identical to that found in TGFb knockout mice (Travis
et al. 2007). Mice with a mutated form of TGFb1
blocking integrin-mediated activation develop a pheno-
type identical to that of TGFb1 null mice (Yang et al.
2007) and similar to that of avo rb8 deﬁcient mice
(Bader et al. 1998; Zhu et al. 2002a, b). Finally, genetic
loss of TGFb in mice results in apoptotic neuronal loss
accompanied by diffuse astrogliosis, and increased neu-
ronal susceptibility to kainic acid-induced excitotoxic
injury (Brionne et al. 2003). Moreover, in vivo TGF-b1
administration in mice protects against ischemic brain
injury (McNeill et al. 1994; Zhu et al. 2002a, b), and
overexpression of TGFb1 from astrocytes protects against
excitotoxic neuronal injury (Brionne et al. 2003). While
these experiments support b8’s role in the activation of
TGFb, and TGFb’s role in neuroprotection, there has
been little direct evidence demonstrating transcellular
activation of neuroprotective signaling pathways by b8.
Li et al. (2009) provide such evidence. They show that in
the presence of b8 expressing astrocytes, TGFb protects
against hypoxia-induced apoptotic cell death, in part by
upregulating canonical antiapoptotic proteins BCL2 and
BCLxl. Importantly, BCLxl is induced by TGFb1 via
TGFb receptor, ALK1 activation of NF-kappaB, pro-
moting neuronal survival after injury (Ko ¨nig et al. 2005).
It will be interesting to see if this same b8–TGFb–ALK1
pathway is important for neuronal maintenance and for
protection against hypoxic ischemic injury in vivo.
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As was previously shown by other groups (Cambier et al.
2005; Mobley et al. 2009), Li et al. (2009) demonstrate that
astrocyte-derived b8 activates TGFb. Different from other
studies (Cambier et al. 2005), however, they found that
neither matrix metaloprotease (MMP) inhibition nor b8
knockdown could completely abrogate TGFb activation.
While the authors note this may be due to ineffective MMP
inhibition, or due to incomplete b8 knockdown, it is also
possible that alternative activators of TGFb are upregulated
in response to hypoxia, such as other integrins or receptors.
For example, the VEGF co-receptor, neuropilin 1 (Nrp1) is
highly expressed on neurons, regulates neuroprotection in
response to hypoxia (Oosthuyse et al. 2001), and was
recently found to bind to and activate TGFb (Glinka and
Prud’homme 2008). Interestingly, there are numerous
parallels between Nrp1 and b8. For instance, Nrp1 and b8
knockouts have similar cerebrovascular phenotypes. Also,
the adult neurological phenotype of avo rb8 deﬁcient mice
(McCarty et al. 2005; Proctor et al. 2005; Mobley et al.
2009) is strikingly similar to that of mice with deletion of
the hypoxia-response element in the VEGF promoter
(Oosthuyse et al. 2001), where hypoxia-induced VEGF was
found to have a neuroprotective role mediated in part
through neuronal Nrp1. Considering these parallels, it will
be interesting to determine whether neuro-glial Nrp1 can
speciﬁcally activate TGFb in response to hypoxia, and
whether this occurs in the context of the b8–TGFb
interaction.
Hypoxia-Induced b8 Expression
Li et al. (2009) show that astocytic b8 is upregulated in
response to hypoxemia and that the timing of hypoxia-
induced TGFb activation mirrors peak expression levels of
b8. Why might b8 expression be responsive to hypoxia/
ischemia? During development, b8 plays an essential role in
vascular ingression and remodeling in the brain (Zhu et al.
2002a, b; Proctor et al. 2005). Here, it is plausible that glial-
derived b8 regulates neovascularization, coupling the met-
abolic needs of developing neuroepithelial cells to the
vasculature that supplies oxygen and nutrients. It is tempt-
ing to speculate that b8 plays a similar dual role in regu-
lating neo-vascularization and neuronal survival in response
to hypoxic damage. How does hypoxia signal astrocytes to
upregulate b8? Based on the observations of Li etal. (2009),
b8 may have direct or indirect autocrine signaling effects
through TGFb. TGFb and hypoxia cooperatively signal
through hypoxia inducible factor (HIF)-1a to regulate
transcription of endothelial-derived VEGF, and control
angiogenesis and endothelial apoptosis (Ferrari et al. 2006;
Sa ´nchez-Elsner et al. 2001). HIF1a and its major target
gene, VEGF, are upregulated in response to hypoxia/
ischemia, and may protect against neuronal cell death in this
setting (Sheldon et al. 2009). Considering these recent
reports, it will be important to determine whether b8i s
involved in regulation of HIF1a and VEGF, and alterna-
tively how hypoxia, HIF1a and VEGF may regulate
expression of b8. This line of study may more fully eluci-
date the pathophysiology of hypoxic ischemic brain injury
and could help identify novel treatment targets. Taken
together the ﬁndings of Li et al. (2009), one may speculate
that b8 is critically important for neuronal maintenance and
protection against hypoxic insult in vivo. Testing of this
hypothesis will require astrocyte speciﬁc deletion of b8, and
in vivo characterization of these mice in various injury
paradigms including hypoxia/ischemia brain injury.
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